BioMelbourne Network
Progressing BioIndustry

News and Opinions

Previous1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9

2014

July

Acrux Appoints New CEO

25th July, 2014 - Acrux (ASX: ACR) today announced the appointment of a new Chief Executive Officer and Managing Director, Mr. Michael Kotsanis. Michael is currently Chief Commercial Officer of Synthon Holding BV in the Netherlands. He has 25 years’ experience in the global pharmaceutical industry, beginning his career with Boehringer Ingelheim before moving to F. H. Faulding (which was acquire... read more…

ADMEDUS INCREASES STAKE IN IAN FRAZER’S VACCINES

24th July, 2014 -  Now owns over 66% of Admedus Vaccines  Positive interim Phase I HSV-2 data     Phase II HSV-2 programme scheduled to be initiated by end of this year Admedus (ASX: AHZ) today announced that it has increased its ownership in Admedus Vaccines, the platform vaccine development company led by Professor Ian Frazer. Over the last twelve months Admedus has increased its ho... read more…

Starpharma and Ansell Get approval for HIV-killing Condom

23rd July, 2014 - An Australian-developed virus-killing condom is a step closer to sale, following a key regulatory approval. Australian biotech firm Starpharma has developed an antiviral compound called VivaGel that laboratory tests have shown can inactivate up to 99.9 per cent of HIV, herpes and some other sexually transmitted viruses, reducing the risk of transmission. It has teamed up wit... read more…

dorsaVi to commence sale of ViMove in the US following FDA clearance

23rd July, 2014 - Wearable medical device company dorsaVi Limited (ASX: DVL) has today announced it will commence launch of ViMove in the United States following 510K clearance by the US Food and Drug Administration (FDA) for measuring, recording, and reporting on movement and muscle activity of the lower back / lumbar spine. “This is a terrific achievement for dorsaVi and opens up substantial... read more…

Phosphagenics' $19.3 million Capital Raising

11th July, 2014 - • Includes $3 million Share Purchase Plan• Upcoming opioid pain patch trials fully funded 11 July 2014, Melbourne:  Australian drug delivery company, Phosphagenics Limited (ASX:POH; OTCQX:PPGNY),has raised $19.3 million via a placement of $16.3 million to institutional and sophisticated investors in Europe, USA, Asia and Australia and $3 million from a share purchase plan (SP... read more…

Melbourne hosting the 20th International AIDS Conference (AIDS 2014)

9th July, 2014 - Participants from the biotechnology sector highlighted that Melbourne has the capability in this sector but it is challenging to promote it to potential clients who have not been to Melbourne and experienced the facilities. For international investors, seeing the facilities and the people who are part of a project is critical. Participants know that when investors visit Melbou... read more…

LBT INNOVATIONS PRESENTS RESULTS OF MOST EXTENSIVE STUDY OF LANDMARK APAS® TECHNOLOGY AT AUSTRALIAN CONFERENCE

7th July, 2014 - Australian  medical  technology  developer,  LBT  Innovations Limited  (ASX:  LBT),  yesterday presented the results of its most extensive study to date into the efficacy of its Automated Plate Assessment System (APAS®) – a breakthrough culture plate analysis system based on the company’s innovative intelligent image interpretation platform. The presentation by LBT’s Senior Mi... read more…

BioMelbourne Network Announces New CEO

4th July, 2014 - On behalf of the BioMelbourne Network board, I am delighted to announce the appointment of Dr Krystal Evans to the role of Chief Executive Officer. She will commence her full time duties in early August 2014 but will begin engagement with our members and secretariat during the month of July. Krystal is a well recognised advocate for science and technology in Australia, with a ... read more…

dorsaVi acquires Australian Workplace Compliance to drive OH&S market expansion

4th July, 2014 - Medical device company dorsaVi Limited (ASX: DVL) (“the Company”) has today announced the acquisition of Australian Workplace Compliance Pty Ltd to increase the Company’s service offering and client base in the occupational health and safety (OH&S) market. Australian Workplace Compliance was founded by Mark Heaysman and provides OH&S operational and procedural analysis, suppor... read more…

d3 Medicine LLC and Viroclinics Biosciences BV form Virology Drug Development Alliance

2nd July, 2014 - We are thrilled to announce today that we have formalised collaborations with Viroclinics Biosciences - a recognised global leader in diagnostic, preclinical and clinical operation services in the virology space. Please see the attached press release. Together we seek to provide biopharmaceutical customers with an integrated solution to accelerate the preclinical and clinical ... read more…